Current data display the appearance of myelin basic protein (MBP) and DNA-hydrolyzing abzymes in the blood of patients with MS [19,20,21,22,23], SLE [24,25,26], and several other AI pathologies [6,7,8,9,10,11]. This evidence concerns the gene MBP and myeloid sarcoma.